Journal
BIOLOGICAL PSYCHIATRY
Volume 86, Issue 11, Pages 864-871Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.biopsych.2019.05.021
Keywords
Alcohol drinking paradigm; Alcohol use disorder; Craving; Kappa opioid receptor; Naltrexone; Positron emission tomography
Categories
Funding
- National Institute on Alcohol Abuse and Alcoholism Grant [AA021818]
- National Center for Advancing Translational Sciences [UL1 TR000142]
- National Institute of Mental Health [MH091537]
- Yale Center for Translational Neuroscience of Alcoholism
Ask authors/readers for more resources
BACKGROUND: Naltrexone is a nonselective opioid receptor antagonist used as a treatment for alcohol use disorder. However, only modest clinical effects have been observed, possibly because of limited knowledge about the biological variables affecting the efficacy of naltrexone. We investigated the potential role of the kappa opioid receptor (KOR) in the therapeutic effect of naltrexone. METHODS: A total of 48 non-treatment-seeking heavy drinkers (16 women) who met DSM-IV criteria for alcohol dependence participated in two alcohol drinking paradigms (ADPs) separated by a week of open-label naltrexone (100 mg daily). Craving, assessed with the Alcohol Urge Questionnaire and the Yale Craving Scale, and drinking behavior were recorded in each ADP. Prior to naltrexone initiation, KOR availability was determined in the amygdala, hippocampus, pallidum, striatum, cingulate cortex, and prefrontal cortex using positron emission tomography with [C-11]LY2795050. RESULTS: Participants reported lower levels of craving (Yale Craving Scale: -11 +/- 1, p < .0001; Alcohol Urge Questionnaire: -6 +/- 0.6, p < .0001) and consumed fewer drinks (-3.7 +/- 4, p < .0001) during the second ADP following naltrexone therapy. The observed reduction in drinking was negatively associated with baseline KOR availability in the striatum (p = .005), pallidum (p = .023), and cingulate cortex (p = .018). Voxelwise analysis identified clusters in the bilateral insula, prefrontal, and cingulate cortex associated with the reduction in drinking (p < .0001). In addition, KOR availability in all evaluated brain regions was associated with craving measured in both ADPs. CONCLUSIONS: The KOR is implicated in drinking and craving following naltrexone therapy in alcohol use disorder.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available